Researchers
Svorcan, Petar
Results 1-20 of 52
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | The role of GSTM1 and GSTT1 deletion variants and alcohol consumption profile in the development of alcoholic liver cirrhosis![]() | Nešić, Branka; Jelovac, Marina | Article | 23M23 |
| 2025 | Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis![]() | Milašinović, Bojana | Article | 21aM21a |
| 2025 | Uticaj anemije na koncentracije infliksimaba i ishode lečenja kod pacijenata sa inflamatornim bolestima creva![]() | Homšek, Ana | Conference Paper | Mp. category will be shown later |
| 2025 | Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study![]() | Mitrović, Miloš; Stanković-Popović, Verica | Article | 21M21 |
| 2024 | Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability![]() | Jovanović, Marija | Article | 21M21 |
| 2024 | Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics![]() | Marković, Srđan | Article | 21aM21a |
| 2023 | Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients![]() | Marković, Srđan | Conference Paper | Mp. category will be shown later |
| 2023 | Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s disease![]() | Homšek, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | The impact of synbiotic treatment on the levels of gut-derived uremic zoxins, inflammation, and gut microbiome of chronic kidney disease patients - a randomized trial![]() | Mitrović, Miloš; Stanković-Popović, Verica | Article | 21M21 |
| 2021 | The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy![]() | Marković, Srđan T. | Other | Mp. category will be shown later |
| 2020 | Micro-elimination of HCV as a possible therapeutic strategy: Our experience and a review of literature![]() | Bojovic, Ksenija; Babić, Jasmina; Mijailovic, Zeljko | Article | Mp. category will be shown later |
| 2019 | Real-life data on the efficacy and safety of ombitasvir/paritaprevir//ritonavir + dasabuvir + ribavirin in the patients with genotype 1 chronic hepatitis c virus infection in Serbia![]() | Simonović-Babić, Jasmina | Article | 23M23 |
| 2019 | Mortality predictors of patients suffering of acute pancreatitis and development of intraabdominal hypertension![]() | Stojanović, Maja; Svorcan, Petar V. | Article | 23M23 |
| 2019 | Istraživanje osobina ličnosti obolelih od hroničnih zapaljenskih bolesti creva![]() | Trikoš, Lela; Jojić, Njegica | Article | 23M23 |
| 2017 | Intraabdominalni pritisak i prokalcitonin su validni markeri evaluacije akutnog pankreatitisa (intraabdominalni pritisak i prokalcitonin)![]() | Stojanović, Maja; Svorcan, Petar | Article | 53M53 |
| 2017 | The influence of intraabdominal pressure on the mortality rate of patients with acute pancreatitis![]() | Svorcan, Petar | Article | 22M22 |
| 2017 | Remodeling of extracellular matrix of the lamina propria in the uninvolved human rectal mucosa 10 and 20 cm away from the malignant tumor![]() | Despotović, Sanja | Article | 22M22 |
| 2015 | Intraabdominalna hipertenzija i abdominalni kompartment sindrom u jedinici intenzivnog lečenja![]() | Svorcan, Petar | Article | 53M53 |
| 2015 | Boceprevir in genotype 1 chronic hepatitis C : first experiences in Serbia![]() | Simonović-Babić, Jasmina | Article | 23M23 |
| 2015 | Colitis and "diaphragm disease" of the colon in hemodialysis patient due to prolonged use of non-steroidal anti-inflammatory drug![]() | Dimković, Nada | Article | 51M51 |
